Ingenia

Feb 21, 2023

Investors have been hitting the sell button on these shares on Tuesday… James Mickleboro has been a Motley Fool contributor since late 2015. After studying economics at university back home in the United Kingdom, James came to live in Australia and managed to land a job at an Australian fund manager. This was the start of a love affair with Australian equities and he hasn't looked back since. James is part of the CFA Institute's Chartered Financial Analyst program and hopes it teaches him how to become an astute investor which allows him to help others with their own investing. Outside of reading and researching he spends many a late night watching the English Premier League and Seinfeld reruns. Latest posts by James Mickleboro ( see all ) Image source: Getty Images You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More The S&P/ASX 200 Index (ASX: XJO) has dropped into the red on Tuesday. In afternoon trade, the benchmark index is down 0.25% to 7,333.1 points. Four ASX shares that are falling more than most today are listed below. Here’s why they are dropping: The A2 Milk share price is down a further 5% to $6.14. This morning, the team at Credit Suisse responded to this infant formula company’s half-year results by downgrading its shares to an underperform rating with a $5.10 price target. Its analysts have concerns that overall infant formula demand could fall materially in China in 2023. The Altium share price is down 6% to $37.60. This follows the release of the electronic design software company’s half-year results after the market close on Monday. Although Altium’s earnings came in ahead of expectations, investors appear to be focusing more on its revenue, which was softer than consensus estimates. The Cogstate share price was down 14% to $1.63 before being hurried into a trading halt. Management advised that the trading halt has been requested so the digital brain health assessments company can respond to a price query request from the ASX. Its shares are now down almost 30% in a week without any news.